Cas:43112-41-0 3-(Trimethylsilyl)-1,3-thiazolidine-2-thione manufacturer & supplier

Chemical Name:3-(Trimethylsilyl)-1,3-thiazolidine-2-thione

CAS.NO:43112-41-0

Synonyms:3-trimethylsilanyl-thiazolidine-2-thione;3-trimethylsilanyl-oxetan-2-one;Trimethylsilyl)-2-thiazolidinethione

Molecular Formula:C₆H₁₃NS₂Si

Molecular Weight:191.39000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:218ºC

Density:1.11

Index of Refraction:

PSA:60.63000

Exact Mass:191.02600

LogP:2.09290

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 3-trimethylsilanyl-thiazolidine-2-thione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Trimethylsilyl)-2-thiazolidinethione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-trimethylsilanyl-oxetan-2-one Use and application,Trimethylsilyl)-2-thiazolidinethione technical grade,usp/ep/jp grade.

Related News: At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. 3-(Trimethylsilyl)-1,3-thiazolidine-2-thione manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 3-(Trimethylsilyl)-1,3-thiazolidine-2-thione supplier We partner with life science companies of all sizes, drawing on over 20 years of industry experience. 3-(Trimethylsilyl)-1,3-thiazolidine-2-thione vendor At the same time, due to the increase in production costs and environmental protection cost pressures in Europe and the United States, as well as the improvement of process technology, production quality, and registration and certification capabilities of China’s bulk drug manufacturers, bulk drug companies have accelerated their transfer to China, and the bulk drug industry in China has produced Scale continues to increase. 3-(Trimethylsilyl)-1,3-thiazolidine-2-thione factory At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world.